Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Rheumatoid Arthritis

NCT03445715 is registered in ClinicalTrials.gov with Arthrogen as lead sponsor.

NCT NCT03445715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03445715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Rheumatoid Arthritis
Lead sponsor
Arthrogen
Phase
Phase 1
Overall status
Unknown status
Start date
January 3, 2018
Completion date
January 31, 2020
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis